Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C

NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS

Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

Inhibitors of mammalian tight junction opening

Selective caspase inhibitors and uses thereof

Co-crystals and pharmaceutical compositions comprising the same

HCV NS3 protease inhibitors

Macrocyclic compounds as hepatitis C virus inhibitors

HCV NS3 protease inhibitors

Inhibitors of interleukin-1 beta converting enzyme

Therapeutic compounds

Organic compounds and their uses

MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS

PROBE COMPOUNDS FOR PROTEIN TYROSINE PHOSPHATASE (PTP) AND PRECURSORS THEREOF

BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM

Method for the stereoselective preparation of amino acid derivatives

HCV NS3 protease inhibitors

Tertiary amine substituted peptides useful as inhibitors of HCV replication

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

Lipid tripeptide-based hydrogelator and hydrogel

Nucleic acid binding compounds and methods of use

Peptide derivatives and cosmetic composition comprising the same

Derivatised proline containing peptide compounds as protease inhibitors

PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES

Methods and intermediates for chemical synthesis of polypeptides and proteins

PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER

IAP BIR DOMAIN BINDING COMPOUNDS

DRUG OR FOOD CONTAINING A PEPTIDE

SUBSTITUTED 1,2-ETHYLENEDIAMINES, METHODS FOR PREPARING THEM AND USES THEREOF

THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES

Imaging probes

Thrombin substrate and assay for determining the level of bioactive thrombin in a sample

Macrocyclic compounds as antiviral agents

Processes and intermediates

INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE

PEPTOID COMPOUNDS

HCV NS3 PROTEASE INHIBITORS

Antimicrobial peptides

Chemical linkers and cleavable substrates and conjugates thereof

Compounds for enzyme inhibition

Compounds for enzyme inhibition

Methods and compositions for treating amyloid-related diseases

Peptides and methods using same for diagnosis and treatment of amyloid-associated disease

HCV NS3 Protease Inhibitors

Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

NOVEL SMALL MOLECULE DNAK INHIBITORS

Inhibitors of Hepatitis C NS3 Protease

HCV protease inhibitors and uses thereof

Selective Caspase Inhibitors

Processes and intermediates

PEPTIDE-BASED COMPOUNDS AS NEW INHIBITORS OF METALLOECTOPEPTIDASES, COMPOSITIONS COMPRISING SAID COMPOUNDS AND THEIR PHARMACEUTICAL AND COSMETIC USES

HCV protease inhibitors and uses thereof

CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTION

HCV protease inhibitors and uses thereof

METHOD FOR DEGRADING PEPTIDES, METHOD FOR ANALYZING PEPTIDES, DEVICE FOR DEGRADING PEPTIDES AND DEVICE FOR ANALYZING PEPTIDES

MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS

Peptides directed for diagnosis and treatment of amyloid-associated diseases

PROCESS FOR DETECTING ENZYME ACTIVITY IN AN IMMUNOASSAY

CYCLIC MALONAMIDES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

Agents for the Detection and Modulation of B-Cells and Antibodies

Process for preparing macrocyclic compounds

Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof

Macrocyclic compounds as antiviral agents

HCV protease inhibitors and uses thereof

IMMUNOMODULATORY DAIRY PEPTIDES AND USES THEREOF

Hepatitis C virus inhibitors

MACROCYCLIC GHRELIN RECEPTOR ANTAGONISTS AND INVERSE AGONISTS AND METHODS OF USING THE SAME

Hepatitis C virus inhibitors

CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION

MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS

Macrocyclic compounds as antiviral agents

Plasma protein-binding ligands

Selective substrates for matrix metalloproteinases

Intermediates for macrocyclic compounds

Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products

Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor

PAR-2 agonist

COMPOUNDS FOR ENZYME INHIBITION

SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS

Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof

Compounds for enzyme inhibition

Macrocyclic Modulators of the Ghrelin Receptor

OMI PDZ MODULATORS

Triazole-containing macrocyclic HCV serine protease inhibitors

Antiviral compounds

Macrocyclic oximyl hepatitis C serine protease inhibitors

Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

Quinoxalinyl derivatives

HCV protease inhibitors and uses thereof

C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors

Methods of using macrocyclic modulators of the ghrelin receptor

Biologically active C-terminal arginine-containing peptides

Macrocyclic tetrazolyl hepatitis C serine protease inhibitors

Processes for intermediates for macrocyclic compounds

Spatially-defined macrocyclic compounds useful for drug discovery

Organic compounds and their uses

Compounds for proteasome enzyme inhibition

HCV NS3 protease inhibitors

Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides

Modified Amino Acids

Anti-cancer compounds

HCV NS3 protease inhibitors

Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme

INHIBITORS OF SERINE PROTEASE, PARTICULARLY HCV NS3-NS4A PROTEASE

Process for Production of (1,3-Disubstituted Indolyl)-Urea Derivatives, Intermediates Therefor, and Process for Production of the Intermediates

PAR-2 antagonists

Cyclic Isodityrosine Derivatives

Antibody Binding Affinity Ligands

Peptidic compounds

Antibacterial amide macrocycles VI

Growth Hormone Secretagogue Receptor 1A Ligands

BIOLOGICALLY ACTIVE PEPTIDES

PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES CHARACTERIZED BY AN INFLAMMATORY RESPONSE

C-Met receptor regulation by angiotensin IV (AT) receptor ligands

MACROCYCLIC ANTAGONISTS OF THE MOTILIN RECEPTOR FOR MODULATION OF THE MIGRATING MOTOR COMPLEX

Cyclic malonamides as inhibitors of aβ protein production

ANTIBACTERIAL AMIDE-MACROCYCLES V

OXIMYL HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS PROTEASE INHIBITOR

Prion protein ligands and methods of use

N-FUNCTIONALIZED AMIDES AS HEPATITIS C SERINE PROTEASE INHIBITORS

Convergent Solid Phase Peptide Synthesis By Reaction Of Two Fragments Bound To Solid Support

Ring-closing metathesis process for the preparation of macrocyclic peptides

Biologically active peptide comprising tyrosyl-seryl-valine (YSV)

Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL)

Biologically active peptides and their new uses

IAP BIR domain binding compounds

Compounds for enzyme inhibition

ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS

Macrocylic oximyl hepatitis C protease inhibitors

Therapeutic uses of tri-, tetra-, penta-, and polypeptides

Plasma protein-binding ligands

Hepatitis C virus inhibitors

Macrocyclic Sh2 Domain Binding Inhibitors

Acyclic oximyl hepatitis C protease inhibitors

Hepatitis C virus inhibitors

Compounds for enzyme inhibition

ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME

Antibacterial amide macrocycles IV

Inhibitors of interleukin-1β converting enzyme

IAP BIR domain binding compounds

Cyclic malonamides as inhibitors of Aβ protein production

Compounds for enzyme inhibition

Inhibitors of serine proteases, particular HCV NS3-NS4A protease

Organic compounds and their uses

Macrocylic oximyl hepatitis C protease inhibitors

Compounds and compositions as channel activating protease inhibitors

Tripeptide prodrug compounds

Biologically active peptide PTTKTYFPHF

Organic Compounds and Their Uses

Depeptidized inhibitors of hepatitis C virus NS3 protease

Biologically active peptide comprising Tyrosyl-seryl-valine(YSV)

Multi-location tractor trailer pneumatic connections

Peptides as NS3-serine protease inhibitors of hepatitis C virus

Biologically Active Peptides

Phenylanine derivatives

Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels

Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids

Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

Compounds for enzyme inhibition

Advanced glycation end-product intermediaries and post-amadori inhibition

Inhibitors of hepatitis C virus NS3 protease

Rapamycin peptides conjugates: synthesis and uses thereof

Antibacterial amide macrocycles

PROCESS FOR PREPARING VAPREOTIDE

Peptoid compounds

Compounds for enzyme inhibition

Antibacterial macrocycles with substituted biphenyl

Processes and intermediates

Antiviral compounds

Antitumor agents

Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof

Orally administered small peptides synergize statin activity

Anti-inflammatory peptides

Molecules that block viral infectivity and methods of use thereof

Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission

Peptides as NS3-serine protease inhibitors of hepatitis C virus

HCV NS3 protease inhibitors

Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases

Methods of using macrocyclic modulators of the ghrelin receptor

Methods and compositions for treating amyloid-related diseases

Method of treating interferon non-responders using HCV protease inhibitor

Biologically active peptides

Administration of HCV protease inhibitors in combination with food to improve bioavailability

Hepatitis C inhibitor peptide analogs

Antibacterial ester macrocycles

Potent and specific immunoproteasome inhibitors

Peptides directed for diagnosis and treatment of amyloid-associated disease

Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof

Novel peptides as NS3-serine protease inhibitors of hepatitis C virus

G-type peptides and other agents to ameliorate atherosclerosis and other pathologies

Process for preparing macrocyclic compounds

Anti-cancer compounds

Biologically active peptide conjugates

Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia

Cyclic malonamides as inhibitors of Aβ protein protection

Melanocortin receptor ligands

Composition for enzyme inhibition

Novel thrombin inhibitors, the preparation and use thereof

Melanocortin receptor ligands

Compounds for enzyme inhibition

Anti-Fc-gamma RIIB receptor antibody and uses therefor

Low molecular weight peptidomimetic growth hormone secretagogues

Compounds for enzyme inhibition

Macrocyclic modulators of the ghrelin receptor

TF binding compounds

Granzyme b inhibitors

Immunosuppressant compounds, methods and uses related thereto

Omi PDZ modulators

Inhibitors of hepatitis C virus NS3 protease

Antibacterial amide macrocyles

Antitumor agents

Compounds for enzyme inhibition

Piperidine compounds

Compounds with growth hormone releasing properties

Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease

Macrocyclic peptides active against the hepatitis C virus

Selective substrates for matrix metalloproteinases

Non-peptidic BRS-3 agonists

Orally administered small peptides synergize statin activity

Depeptidized inhibitors of hepatitis C virus NS3 protease

Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia

Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists

Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Macrocyclic peptides active against the hepatitis C virus

Macrocyclic antagonists of the motilin receptor

Process for preparing macrocyclic compounds

Peptoid compounds

Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases

Cyclic malonamides as inhibitors of A-β protein production